Cardiac Mapping Market Analysis | 2023-2028

Cardiac Mapping Market Analysis | 2023-2028

Cardiac Mapping Market Analysis | 2023-2028
Report code - SRHL165 Delivery - 2 Weeks
Cardiac Mapping Market Size, Share, Trends, Forecast, & Growth Analysis: 2023-2028
See more...

Market Insights

The cardiac mapping market was estimated at USD 1.86 billion in 2022 and is likely to grow at a CAGR of 8.76% during 2023-2028 to reach USD 3.09 billion in 2028.

Cardiac-Mapping-Market-Insights

Want to know more about the market scope? Register Here

Market Dynamics

Introduction

Cardiac mapping is the process of identifying the temporal and spatial distribution of myocardial electrical potentials during a particular heart rhythm. It covers several modes of mapping such as body surface, endocardial, and epicardial mapping. The global cardiac mapping market is categorized on the basis of product type into contact mapping systems and non-contact mapping systems. Based on the indication type, it is categorized into atrial fibrillation, atrial flutter, and AVNRT.

Market Drivers

The prime factors that are driving the growth of the cardiac mapping market are-

  • Growing investments, funds, and grants.
  • Increasing incidence of target diseases.
  • Growth in the geriatric population.

Cardiac-Mapping-Market-Dynamics

Want to have a closer look at this market report? Click Here

Key Players

Some of the major players in the market are-

  • Biosense Webster,
  • Abbott, and Boston Scientific Corporation,
  • Medtronic,
  • MicroPort Scientific Corporation,
  • EP Solutions SA,
  • Acutus Medical,
  • Koninklijke Philips N.V. (Royal Philips),
  • Lepu Medical,
  • BIOTRONIK,
  • AngioDynamics,
  • BioSig Technologies,
  • APN Health,
  • CoreMap,
  • Kardium,
  • Catheter Precision,
  • Epmap-System.

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Segments Analysis

Segmentations

List of Sub-Segments

Segments with High Growth Opportunity

Product Type Analysis

Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems

Contact cardiac mapping systems is expected to witness higher growth during the forecast period.

Indication Type Analysis

Atrial Fibrillation, Atrial Flutter, AVNRT, and Others

Atrial fibrillation holds the largest share of the market and is also expected to witness healthy growth during the forecast period.

Regional Analysis

North America, Europe, Asia-Pacific, and Rest of the World

North America is estimated to be the largest market for cardiac mapping during the forecast period.

By Product Type

Based on the product type, the market is segmented as contact cardiac mapping systems and non-contact cardiac mapping systems. Contact cardiac mapping systems are expected to witness higher growth during the forecast period. Contact cardiac mapping systems further include electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. Major advantages of contact cardiac mapping systems such as detection of the precise locations of mapping and ablation catheters in a three-dimensional environment, also with multi-electrode basket catheters, recording just a few beats might be enough to uncover the arrhythmia circuit are the factors increasing its adoption.

By Indication Type

Based on the indication type, the market is segmented as atrial fibrillation, atrial flutter, AVNRT, and other arrhythmias. Atrial fibrillation holds the largest share of the market and is also expected to witness healthy growth during the forecast period.

Regional Insights

In terms of regions, North America is estimated to be the largest market for cardiac mapping during the forecast period. The increase in the approval rate of mapping systems and clinical trials validating cardiac mapping systems in the USA, the high incidence of CVDs, the growing focus of government organizations on providing funding for research, and the increasing geriatric population in Canada are the major factors driving the North American market. Europe and Asia-Pacific are also expected to offer lucrative opportunities during the forecast period.

Cardiac-Mapping-Market-Regional-Insights

Know the high-growth countries in this report. Register Here

Research Methodology

  • This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects today’s cardiac mapping market realities and future market possibilities for the forecast period.
  • The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
  • The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
  • This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
  • More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
  • We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis.
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
  • Market trend and forecast analysis.
  • Market segment trend and forecast.
  • Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
  • COVID-19 impact and its recovery curve
  • Attractive market segments and associated growth opportunities.
  • Emerging trends.
  • Strategic growth opportunities for the existing and new players.
  • Key success factors.

The cardiac mapping market is segmented into the following categories:

By Product Type

  • Contact Mapping Systems
  • Non-contact Cardiac Mapping Systems

By Indication Type

  • Atrial Fibrillation
  • Atrial Flutter
  • AVNRT
  • Other Arrhythmias

By Region

  • North America (Country Analysis: the USA, Canada, and Mexico)
  • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
  • Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
  • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to 3 players)
  • SWOT analysis of key players (up to 3 players)

Market Segmentation

  • Current market segmentation of any one of the product types by indication type.

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

Cardiac mapping is the process of identifying the temporal and spatial distribution of myocardial electrical potentials during a particular heart rhythm.

The cardiac mapping market was estimated at USD 1.86 billion in 2022.

The cardiac mapping market is likely to reach USD 3.09 billion in 2028.

The cardiac mapping market is likely to grow at a CAGR of 8.76% during 2023-2028.

Contact cardiac mapping systems is expected to witness higher growth in the market in the coming years.

Biosense Webster, Abbott, and Boston Scientific Corporation, Medtronic, MicroPort Scientific Corporation, EP Solutions SA, Acutus Medical, Koninklijke Philips N.V. (Royal Philips), Lepu Medical, BIOTRONIK, AngioDynamics, BioSig Technologies, APN Health, CoreMap, Kardium, Catheter Precision, and Epmap-System are among the ley players in the market.

North America is expected to remain the largest market for cardiac mapping during the foreseeable future.